A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 205,500 shares of MIRM stock, worth $8.58 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
205,500
Previous 179,900 14.23%
Holding current value
$8.58 Million
Previous $6.15 Million 30.31%
% of portfolio
0.02%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$33.68 - $44.74 $862,208 - $1.15 Million
25,600 Added 14.23%
205,500 $8.01 Million
Q2 2024

Aug 14, 2024

SELL
$23.57 - $34.85 $403,047 - $595,935
-17,100 Reduced 8.68%
179,900 $6.15 Million
Q1 2024

May 15, 2024

SELL
$24.92 - $30.02 $3.47 Million - $4.18 Million
-139,300 Reduced 41.42%
197,000 $4.95 Million
Q4 2023

Feb 14, 2024

SELL
$27.14 - $34.93 $1.48 Million - $1.91 Million
-54,600 Reduced 13.97%
336,300 $9.93 Million
Q3 2023

Nov 14, 2023

BUY
$24.63 - $32.85 $8.09 Million - $10.8 Million
328,300 Added 524.44%
390,900 $12.4 Million
Q2 2023

Aug 14, 2023

BUY
$23.51 - $30.09 $759,373 - $971,907
32,300 Added 106.6%
62,600 $1.62 Million
Q1 2023

May 15, 2023

SELL
$19.19 - $24.1 $949,905 - $1.19 Million
-49,500 Reduced 62.03%
30,300 $727,000
Q4 2022

Feb 14, 2023

SELL
$17.59 - $23.83 $564,639 - $764,943
-32,100 Reduced 28.69%
79,800 $1.56 Million
Q3 2022

Nov 14, 2022

SELL
$19.98 - $29.44 $921,078 - $1.36 Million
-46,100 Reduced 29.18%
111,900 $2.35 Million
Q2 2022

Aug 15, 2022

SELL
$18.42 - $27.5 $843,636 - $1.26 Million
-45,800 Reduced 22.47%
158,000 $3.08 Million
Q1 2022

May 16, 2022

BUY
$15.5 - $23.93 $558,899 - $862,867
36,058 Added 21.5%
203,800 $4.49 Million
Q4 2021

Feb 14, 2022

BUY
$13.05 - $19.35 $968,858 - $1.44 Million
74,242 Added 79.4%
167,742 $2.68 Million
Q3 2021

Nov 15, 2021

BUY
$13.95 - $20.18 $163,215 - $236,106
11,700 Added 14.3%
93,500 $1.86 Million
Q2 2021

Aug 16, 2021

BUY
$15.84 - $20.6 $199,584 - $259,560
12,600 Added 18.21%
81,800 $1.41 Million
Q1 2021

May 17, 2021

BUY
$16.29 - $21.92 $750,969 - $1.01 Million
46,100 Added 199.57%
69,200 $1.37 Million
Q4 2020

Feb 16, 2021

BUY
$15.75 - $25.45 $363,825 - $587,895
23,100 New
23,100 $403,000

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.53B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.